Cash · 2014–2025

Lakefront Biotherapeutics cash

$103M+54.7% · FY2025

Lakefront Biotherapeutics (LKFT) reported $103M in cash for fiscal 2025, +54.7% year on year.

$228M2014$370M2015$1.0B2016$1.4B2017$1.5B2018$2.1B2019$2.6B2020$2.5B2021$542M2022$184M2023$66.7M2024$103M2025
Lakefront Biotherapeutics — Cash, 2014–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$103M+54.7%Open →
FY20242024-12-31$66.7M−63.8%Open →
FY20232023-12-31$184M−66.0%Open →
FY20222022-12-31$542M−78.6%Open →
FY20212021-12-31$2.5B−3.5%Open →
FY20202020-12-31$2.6B+25.3%Open →
FY20192019-12-31$2.1B+41.5%Open →
FY20182018-12-31$1.5B+7.0%Open →
FY20172017-12-31$1.4B+34.6%Open →
FY20162016-12-31$1.0B+176.9%Open →
FY20152015-12-31$370M+62.6%Open →
FY20142014-12-31$228M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2014–2025 compound annual growth −6.9%

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Lakefront Biotherapeutics cash |url=https://companiesranked.com/en/company/lakefront-biotherapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Lakefront Biotherapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/lakefront-biotherapeutics/cash-on-hand

BibTeX

@misc{companiesranked-en-company-lakefront-biotherapeutics-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Lakefront Biotherapeutics cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/lakefront-biotherapeutics/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001104659-26-035163 · March 26, 2026

{{cite web |title=Lakefront Biotherapeutics cash — 20-F (0001104659-26-035163) |url=https://www.sec.gov/Archives/edgar/data/1421876/000110465926035163/glpg-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Lakefront Biotherapeutics overview